The compensation assay was implemented, indicating that overexpression of miR-195-5p weakened the cancer-promoting function mediated by TUG1, which means TUG1 serves as a sponge of miR-195-5p to facilitate the in-vitro growth and cisplatin resistance of CRC cells. The gene discussed is TUG1; the disease is colorectal carcinoma.